An Open Labeled, Multicentre, Randomized Phase II Trial of Combination Gemcitabine and Carboplatin Chemotherapy in Patients with Metastatic or on-going Recurrent Nasopharyngeal Carcinoma [Gemcitabine Study]
MOH
Dr. Christina Ng Van Tze
Ongoing
12 months
2.
A Phase II, randomized controlled trial of Foscan-mediated Photodynamic Therapy versus Branch therapy in patients with Recurrent of Persistent Nasopharyngeal Carcinoma